Study record

The Effect of Chronic Endurance Exercise on Serum Levels of MOTS-c and Humanin in Professional Athletes

Alser M, Ramanjaneya M, Rizwana Anwardeen N et al. · Rev Cardiovasc Med · 2022

Human obs.SeveralEvidence tier B

What this study reported

Measured serum MOTS-c and humanin by ELISA and reported lower MOTS-c and higher humanin in professional athletes than in sedentary controls. Reported that within the athlete groups humanin was lower in high endurance than in low/moderate endurance athletes of the same sex and age group, that MOTS-c did not differ between those subgroups, and that the two peptides were strongly correlated in athletes but not in controls.

Limitations

Described by the authors as pilot data; cross-sectional single-timepoint sampling with controls not matched for body composition or diet; unequal and small subgroups, particularly the high endurance group; training load characterised only by broad endurance category.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
Specieshuman
System studiedSerum MOTS-c and humanin in professional endurance athletes and non-athlete controls, measured by ELISA
PopulationProfessional low/moderate and high endurance athletes and non-athlete sedentary controls
DesignCross-sectional comparison of athletes and non-athletes
Sample size as reported105 participants (30 non-athlete controls, 47 low/moderate endurance athletes, 28 high endurance athletes)
Control group30 non-athlete sedentary controls
Route (data field only)Not reported
Endpoints measuredserum MOTS-c; serum humanin; correlation between the two peptides
Pathways measuredNot reported
Research areasExercise · Mitochondrial biology
Evidence tierB — Other human study
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Small
Controls
Limited
Outcome validity
Exploratory
Support for its own conclusion
Weak

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.